Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Hepatitis and pneumonitis durin adalimumab therapy in Crohn? Disease: mind the histoplasmosis!

Pinheiro Bdo V, Delgado Ade A, Chebli JM.

Arq Gastroenterol. 2014 Jan-Mar;51(1):73-6.

PMID:
24760069
[PubMed - in process]
Free Article
2.

A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease.

Dretzke J, Edlin R, Round J, Connock M, Hulme C, Czeczot J, Fry-Smith A, McCabe C, Meads C.

Health Technol Assess. 2011 Feb;15(6):1-244. doi: 10.3310/hta15060. Review.

PMID:
21291629
[PubMed - indexed for MEDLINE]
Free Article
3.

Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: a case series.

Dotson JL, Crandall W, Mousa H, Honegger JR, Denson L, Samson C, Cunningham D, Balint J, Dienhart M, Jaggi P, Carvalho R.

Inflamm Bowel Dis. 2011 Jan;17(1):56-61. doi: 10.1002/ibd.21378.

PMID:
20645322
[PubMed - indexed for MEDLINE]
4.

Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trial.

Panaccione R, Loftus EV Jr, Binion D, McHugh K, Alam S, Chen N, Guerette B, Mulani P, Chao J.

Can J Gastroenterol. 2011 Aug;25(8):419-25.

PMID:
21912766
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.

Magro F, Portela F.

BioDrugs. 2010 Dec 14;24 Suppl 1:3-14. doi: 10.2165/11586290-000000000-00000. Review.

PMID:
21175228
[PubMed - indexed for MEDLINE]
6.

Reactivation histoplasmosis after treatment with anti-tumor necrosis factor alpha in a patient from a nonendemic area.

Jain VV, Evans T, Peterson MW.

Respir Med. 2006 Jul;100(7):1291-3. Epub 2006 Mar 20.

PMID:
16545951
[PubMed - indexed for MEDLINE]
Free Article
7.

A case of adalimumab-induced pneumonitis in a 45-year-old man with Crohn's disease.

Reid JD, Bressler B, English J.

Can Respir J. 2011 Sep-Oct;18(5):262-4.

PMID:
21969926
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience.

Lawrance IC, Radford-Smith GL, Bampton PA, Andrews JM, Tan PK, Croft A, Gearry RB, Florin TH.

J Gastroenterol Hepatol. 2010 Nov;25(11):1732-8. doi: 10.1111/j.1440-1746.2010.06407.x.

PMID:
21039834
[PubMed - indexed for MEDLINE]
9.

Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.

Behm BW, Bickston SJ.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD006893. doi: 10.1002/14651858.CD006893. Review.

PMID:
18254120
[PubMed - indexed for MEDLINE]
10.

Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept.

Lee JH, Slifman NR, Gershon SK, Edwards ET, Schwieterman WD, Siegel JN, Wise RP, Brown SL, Udall JN Jr, Braun MM.

Arthritis Rheum. 2002 Oct;46(10):2565-70.

PMID:
12384912
[PubMed - indexed for MEDLINE]
Free Article
11.

Histoplasmosis after treatment with anti-tumor necrosis factor-alpha therapy.

Wood KL, Hage CA, Knox KS, Kleiman MB, Sannuti A, Day RB, Wheat LJ, Twigg HL 3rd.

Am J Respir Crit Care Med. 2003 May 1;167(9):1279-82. Epub 2003 Feb 13.

PMID:
12615627
[PubMed - indexed for MEDLINE]
12.

Long-term efficacy of adalimumab in paediatric Crohn's disease patients naïve to other anti-TNF therapies.

Martín-de-Carpi J, Pociello N, Varea V.

J Crohns Colitis. 2010 Nov;4(5):594-8. doi: 10.1016/j.crohns.2010.04.002. Epub 2010 May 1.

PMID:
21122566
[PubMed - indexed for MEDLINE]
13.

Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn's disease.

Ma C, Walters B, Fedorak RN.

World J Gastroenterol. 2013 Jun 7;19(21):3347-51. doi: 10.3748/wjg.v19.i21.3347. Review.

PMID:
23745038
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Suspected de novo Hepatitis B in a Patient Receiving Anti-Tumor Necrosis Factor Alpha Therapy for the Treatment of Crohn's Disease.

Ishida T, Nagamatsu H, Ueo T, Narita R, Takahashi K, Urabe M, Yanai Y, Togo K.

Case Rep Gastroenterol. 2014 Jan 25;8(1):44-50. doi: 10.1159/000358554. eCollection 2014 Jan.

PMID:
24574949
[PubMed]
Free PMC Article
15.

Development of primary malignant melanoma during treatment with a TNF-α antagonist for severe Crohn's disease: a case report and review of the hypothetical association between TNF-α blockers and cancer.

Kouklakis G, Efremidou EI, Pitiakoudis M, Liratzopoulos N, Polychronidis ACh.

Drug Des Devel Ther. 2013;7:195-9. doi: 10.2147/DDDT.S41889. Epub 2013 Mar 27. Review.

PMID:
23569358
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Oral histoplasmosis: an unusual presentation.

Narayana N, Gifford R, Giannini P, Casey J.

Head Neck. 2009 Feb;31(2):274-7. doi: 10.1002/hed.20882.

PMID:
18798316
[PubMed - indexed for MEDLINE]
17.

Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens.

Wheat LJ, Kohler RB, Tewari RP.

N Engl J Med. 1986 Jan 9;314(2):83-8.

PMID:
3941695
[PubMed - indexed for MEDLINE]
18.

Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial.

Colombel JF, Sandborn WJ, Rutgeerts P, Kamm MA, Yu AP, Wu EQ, Pollack PF, Lomax KG, Chao J, Mulani PM.

Am J Gastroenterol. 2009 May;104(5):1170-9. doi: 10.1038/ajg.2009.59. Epub 2009 Apr 7.

PMID:
19352339
[PubMed - indexed for MEDLINE]
19.

Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series.

Absah I, Faubion WA Jr.

Inflamm Bowel Dis. 2012 Aug;18(8):1488-92. doi: 10.1002/ibd.21885. Epub 2011 Aug 31.

PMID:
21882301
[PubMed - indexed for MEDLINE]
20.

Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial.

Loftus EV, Feagan BG, Colombel JF, Rubin DT, Wu EQ, Yu AP, Pollack PF, Chao J, Mulani P.

Am J Gastroenterol. 2008 Dec;103(12):3132-41. doi: 10.1111/j.1572-0241.2008.02175.x. Epub 2008 Oct 3. Erratum in: Am J Gastroenterol. 2009 Jul;104(7):1894.

PMID:
18853973
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk